AU2001227702A1 - Osmotic device within an osmotic device - Google Patents

Osmotic device within an osmotic device

Info

Publication number
AU2001227702A1
AU2001227702A1 AU2001227702A AU2770201A AU2001227702A1 AU 2001227702 A1 AU2001227702 A1 AU 2001227702A1 AU 2001227702 A AU2001227702 A AU 2001227702A AU 2770201 A AU2770201 A AU 2770201A AU 2001227702 A1 AU2001227702 A1 AU 2001227702A1
Authority
AU
Australia
Prior art keywords
osmotic device
osmotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001227702A
Inventor
Marcelo A. Coppari
Joaquina Faour
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Osmotica Corp
Original Assignee
PHOENIX USA Inc LAB
Laboratorios Phoenix USA Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PHOENIX USA Inc LAB, Laboratorios Phoenix USA Inc filed Critical PHOENIX USA Inc LAB
Publication of AU2001227702A1 publication Critical patent/AU2001227702A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
AU2001227702A 2000-01-14 2001-01-08 Osmotic device within an osmotic device Abandoned AU2001227702A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17608100P 2000-01-14 2000-01-14
US60176081 2000-01-14
PCT/US2001/000513 WO2001051036A1 (en) 2000-01-14 2001-01-08 Osmotic device within an osmotic device

Publications (1)

Publication Number Publication Date
AU2001227702A1 true AU2001227702A1 (en) 2001-07-24

Family

ID=22642894

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001227702A Abandoned AU2001227702A1 (en) 2000-01-14 2001-01-08 Osmotic device within an osmotic device

Country Status (12)

Country Link
US (1) US6491949B2 (en)
EP (1) EP1246613B1 (en)
AR (1) AR026820A1 (en)
AT (1) ATE484276T1 (en)
AU (1) AU2001227702A1 (en)
BR (1) BRPI0107646B1 (en)
CA (1) CA2396152C (en)
DE (1) DE60143250D1 (en)
ES (1) ES2355099T3 (en)
MX (1) MXPA02006868A (en)
UY (1) UY26533A1 (en)
WO (1) WO2001051036A1 (en)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2221370T3 (en) 1998-04-03 2004-12-16 Egalet A/S COMPOSITION OF CONTROLLED RELEASE.
CA2328628A1 (en) * 1999-12-21 2001-06-21 Cecile J. Schoenheider Moldable compositions
US20070059367A1 (en) * 2000-06-06 2007-03-15 Cherukuri S R Drug Delivery System and Associated Methods
US20100196466A1 (en) * 2000-06-06 2010-08-05 Capricorn Pharma Inc. Drug delivery system
US7674480B2 (en) * 2000-06-23 2010-03-09 Teva Pharmaceutical Industries Ltd. Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
US20040122090A1 (en) * 2001-12-07 2004-06-24 Lipton Stuart A. Methods for treating neuropsychiatric disorders with nmda receptor antagonists
CA2434169C (en) * 2001-01-12 2011-03-15 Sun Pharmaceutical Industries Limited Spaced drug delivery system
RU2324475C2 (en) * 2001-04-10 2008-05-20 Сан Фармасьютикал Индастриз Лимитед Composition released in pulse mode at preset time
IN191028B (en) * 2001-05-17 2003-09-13 Sun Pharmaceutical Ind Ltd
US6838093B2 (en) * 2001-06-01 2005-01-04 Shire Laboratories, Inc. System for osmotic delivery of pharmaceutically active agents
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
US20030050620A1 (en) * 2001-09-07 2003-03-13 Isa Odidi Combinatorial type controlled release drug delivery device
US20030091634A1 (en) * 2001-09-14 2003-05-15 Pawan Seth Delayed release tablet of venlafaxin
US20040253310A1 (en) 2001-09-21 2004-12-16 Gina Fischer Morphine polymer release system
US20040234602A1 (en) 2001-09-21 2004-11-25 Gina Fischer Polymer release system
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
MY148466A (en) * 2001-10-26 2013-04-30 Merck Frosst Canada Ltd Granule formulation
US8329217B2 (en) 2001-11-06 2012-12-11 Osmotica Kereskedelmi Es Szolgaltato Kft Dual controlled release dosage form
HUP0402451A3 (en) * 2001-12-19 2008-04-28 Alza Corp Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
US20040052843A1 (en) * 2001-12-24 2004-03-18 Lerner E. Itzhak Controlled release dosage forms
EP1490029A4 (en) * 2002-03-22 2006-02-22 Ranbaxy Lab Ltd Controlled release drug delivery system of pravastatin
EP1534238A1 (en) * 2002-07-29 2005-06-01 ALZA Corporation Formulations and dosage forms for controlled delivery of topiramate
US20050232995A1 (en) * 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
ATE373472T1 (en) * 2002-07-29 2007-10-15 Alza Corp METHOD AND DOSAGE FORMS FOR THE CONTROLLED DELIVERY OF PALIPERIDONE
US20090162431A1 (en) * 2002-09-21 2009-06-25 Shuyi Zhang Sustained release formulations containing acetaminophen and tramadol
ATE386509T1 (en) * 2002-09-21 2008-03-15 Shuyi Zhang SUSTAINED RELEASE FORMULATION OF ACETAMINOPHEN AND TRAMADOL
WO2004041252A1 (en) 2002-11-08 2004-05-21 Egalet A/S Controlled release carvedilol compositions
US8293799B2 (en) * 2003-12-29 2012-10-23 Osmotica Keresleedelmo és Szolgáltató KFT Osmotic device containing a venlafaxine salt and a salt having an ion in common
US20070077301A1 (en) * 2002-12-23 2007-04-05 Meyer Glenn A Venlafaxine osmotic device formulation
DE602004025159D1 (en) 2003-03-26 2010-03-04 Egalet As Matrix preparations for the controlled administration of drugs
EP2301526B1 (en) 2003-03-26 2016-03-23 Egalet Ltd. Morphine controlled release system
WO2004108067A2 (en) * 2003-04-03 2004-12-16 Sun Pharmaceutical Industries Limited Programmed drug delivery system
US20040202717A1 (en) 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
US7226968B2 (en) * 2003-05-20 2007-06-05 Arch Uk Biocides Limited Composition and use
US7217759B2 (en) * 2003-05-20 2007-05-15 Arch Uk Biocides Limited Composition and use
EP2112920B1 (en) 2003-06-26 2018-07-25 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US20050176693A1 (en) * 2003-08-12 2005-08-11 Boissonneault Roger M. Method of intermittent administration of a pharmaceutical for the treatment of conditions associated with a female's menstrual cycle
US7611728B2 (en) * 2003-09-05 2009-11-03 Supernus Pharmaceuticals, Inc. Osmotic delivery of therapeutic compounds by solubility enhancement
KR101169614B1 (en) * 2003-09-26 2012-08-03 알자 코포레이션 Controlled release formulations exhibiting an ascending rate of release
EP1708684A2 (en) 2003-09-26 2006-10-11 Alza Corporation Drug coating providing high drug loading and methods for providing the same
US8734850B2 (en) 2003-11-25 2014-05-27 Flamel Technologies Oral medicinal product with modified release of at least one active principle in multimicrocapsular form
EP1686967A4 (en) * 2003-11-25 2012-08-08 Smithkline Beecham Cork Ltd Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
US7201920B2 (en) * 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
US20050281875A1 (en) * 2003-12-17 2005-12-22 Sovereign Pharmaceuticals, Ltd. Promethazine containing dosage form
US20050232986A1 (en) * 2003-12-17 2005-10-20 David Brown Dosage form containing promethazine and another drug
WO2005065648A2 (en) * 2003-12-29 2005-07-21 Alza Corporation, Inc., Novel drug compositions and dosage forms of topiramate
US7670624B2 (en) * 2004-01-29 2010-03-02 Astella Pharma Inc. Gastrointestinal-specific multiple drug release system
DE602004001969T2 (en) * 2004-02-20 2007-03-15 Mattern, Udo Oral pharmaceutical composition and process for its preparation
WO2005123039A1 (en) 2004-06-12 2005-12-29 Collegium Pharmaceutical, Inc. Abuse-deterrent drug formulations
US7713550B2 (en) * 2004-06-15 2010-05-11 Andrx Corporation Controlled release sodium valproate formulation
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US7619007B2 (en) * 2004-11-23 2009-11-17 Adamas Pharmaceuticals, Inc. Method and composition for administering an NMDA receptor antagonist to a subject
US20060177380A1 (en) * 2004-11-24 2006-08-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of orally administered pharmaceutical products
US20080152595A1 (en) * 2004-11-24 2008-06-26 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of orally administered pharmaceutical products
US20070231268A1 (en) * 2004-11-24 2007-10-04 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of orally administered pharmaceutical products
CA2588296A1 (en) 2004-11-24 2006-06-01 Neuromolecular Pharmaceuticals, Inc. Composition comprising an nmda receptor antagonist and levodopa and use thereof for treating neurological disease
US20060110327A1 (en) * 2004-11-24 2006-05-25 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of orally administered pharmaceutical products
AR053986A1 (en) 2004-12-03 2007-05-30 Osmotica Pharmaceutical Argent OSMOTIC DEVICE CONTAINING AMANTADINE AND AN OSMOTIC SALT
KR20070102563A (en) * 2005-01-26 2007-10-18 엘란 파마 인터내셔널 리미티드 Controlled release compositions comprising an antipsychotic agent
KR101406456B1 (en) 2005-04-06 2014-06-20 아다마스 파마슈티칼스, 인코포레이티드 Methods and compositions for treatment of cns disorders
EP2502621A1 (en) 2005-06-27 2012-09-26 Valeant International (Barbados) SRL Crystalline forms of bupropion HBr
EP1959923A4 (en) * 2005-08-30 2012-05-02 Piramal Life Sciences Ltd Extended release pharmaceutical composition of metformin and a process for producing it
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
MX2008012009A (en) * 2006-03-20 2008-10-03 Duramed Pharmaceuticals Inc Flexible, compressed intravaginal rings, methods of making and using the same, and apparatus for making the same.
CA2648280C (en) 2006-04-03 2014-03-11 Isa Odidi Controlled release delivery device comprising an organosol coat
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
NZ580972A (en) 2007-06-04 2012-02-24 Egalet Ltd Controlled release pharmaceutical compositions for prolonged effect
CA2733779A1 (en) * 2008-08-13 2010-02-18 James Messina Broad spectrum animal repellent and method
US20110092493A1 (en) * 2008-09-24 2011-04-21 Clark Levi Dose-controlled transdermal promethazine compositions and methods of use
AU2010211220B2 (en) 2009-02-06 2013-08-01 Egalet Ltd. Immediate release composition resistant to abuse by intake of alcohol
CA2766179A1 (en) 2009-06-24 2010-12-29 Egalet Ltd. Controlled release formulations
US8901113B2 (en) 2009-09-30 2014-12-02 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
MX2012006320A (en) 2009-12-02 2013-01-18 Adamas Pharmaceuticals Inc Amantadine compositions and methods of use.
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
PH12015501410A1 (en) 2010-12-22 2015-09-07 Purdue Pharma Lp Encased tamper resistant controlled release dosage forms
EP2654733B1 (en) 2010-12-23 2016-04-06 Purdue Pharma LP Tamper resistant solid oral dosage forms
US9271486B2 (en) 2011-11-10 2016-03-01 James J. Messina Combination animal repellents
CA2877183A1 (en) 2012-07-06 2014-01-09 Egalet Ltd. Abuse deterrent pharmaceutical compositions for controlled release
WO2014081616A1 (en) * 2012-11-21 2014-05-30 Merck Sharp & Dohme Corp. Preparation of precursors for leukotriene antagonists
EP3446685A1 (en) 2012-11-30 2019-02-27 Acura Pharmaceuticals, Inc. Self-regulated release of active pharmaceutical ingredient
KR101840526B1 (en) 2013-02-05 2018-03-20 퍼듀 퍼머 엘피 Tamper resistant pharmaceutical formulations
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
WO2014204933A1 (en) 2013-06-17 2014-12-24 Adamas Pharmaceuticals, Inc. Amantadine compositions and methods of use
CA2943728C (en) 2014-03-26 2020-03-24 Sun Pharma Advanced Research Company Ltd. Abuse deterrent immediate release biphasic matrix solid dosage form
US11103581B2 (en) 2015-08-31 2021-08-31 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists
US10213394B1 (en) 2018-02-15 2019-02-26 Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelõsségû Társaság Composition and method for treating neurological disease
US20190247331A1 (en) 2018-02-15 2019-08-15 Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelõsségû Társaság Composition and method for treating neurological disease
US10213393B1 (en) 2018-02-15 2019-02-26 Osmotica Kereskedelmi és Szolgáltató Korlátolt Feleõsségû Társaság Composition and method for treating neurological disease

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US4111202A (en) 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4285987A (en) * 1978-10-23 1981-08-25 Alza Corporation Process for manufacturing device with dispersion zone
US4278087A (en) 1980-04-28 1981-07-14 Alza Corporation Device with integrated operations for controlling release of agent
US4455143A (en) 1982-03-22 1984-06-19 Alza Corporation Osmotic device for dispensing two different medications
US4449983A (en) 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device
US4608048A (en) * 1984-12-06 1986-08-26 Alza Corporation Dispensing device with drug delivery patterns
PT621032E (en) * 1993-04-23 2001-01-31 Novartis Ag FARMACO CONTROLLED LIBERATION DISTRIBUTION DEVICE
JP3950175B2 (en) 1997-05-30 2007-07-25 オスモティカ・コーポレイション Multi-layer penetrating device

Also Published As

Publication number Publication date
EP1246613A1 (en) 2002-10-09
EP1246613B1 (en) 2010-10-13
CA2396152A1 (en) 2001-07-19
CA2396152C (en) 2008-02-19
US6491949B2 (en) 2002-12-10
WO2001051036A1 (en) 2001-07-19
MXPA02006868A (en) 2004-06-29
ATE484276T1 (en) 2010-10-15
AR026820A1 (en) 2003-02-26
EP1246613A4 (en) 2005-06-29
BR0107646A (en) 2004-07-20
BRPI0107646B1 (en) 2016-08-30
UY26533A1 (en) 2001-09-28
US20020035357A1 (en) 2002-03-21
ES2355099T3 (en) 2011-03-22
DE60143250D1 (en) 2010-11-25

Similar Documents

Publication Publication Date Title
AU2001227702A1 (en) Osmotic device within an osmotic device
AU2001228310A1 (en) Rear-projecting device
AU2001238137A1 (en) Communicating device
AU2758701A (en) Storage device
AU2001294417A1 (en) Operating device
AU2001222241A1 (en) Laser machinning device
AU2001289424A1 (en) Laser device
AU7392501A (en) Connecting device
AU2001279517A1 (en) Connecting device
EP1180823A3 (en) Cable-connection or cable-joint device
AU8293201A (en) Applause device
AU2002214176A1 (en) Stop device
AU2001254745A1 (en) Pellet-freezing device
AU2001241311A1 (en) Cap-signaling device
AU2001279629A1 (en) Positioning device
AUPQ625900A0 (en) Cutting device
AU2002211092A1 (en) Cutting device
AU2001250678A1 (en) Holder-grasping device
AU2001238543A1 (en) Antiextrusion device
AU2001236486A1 (en) Field emission device
AU6269700A (en) Forming device
AU2002214990A1 (en) Storage device
AU2001283078A1 (en) Eye-exercise device
AU2002215241A1 (en) Paper-clipping device
AU2001281849A1 (en) Mechanical coin-testing device